TrialThe New England journal of medicine2013
Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.
Kieron Dunleavy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
240 papers cite itlatest 60 shown
this paperpooled ittrialcites it